prednisone has been researched along with imiquimod in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beyeler, M; Dummer, R | 1 |
Bohmeyer, J; Gellrich, S; Kremer, A; Luger, T; Muche, M; Nashan, D; Stadler, R; Sterry, W | 1 |
Brunetti, G; Cozzi, R; Lo Schiavo, A; Puca, RV; Ruocco, E; Sangiuliano, S | 1 |
Bianchi, L; Campione, E; Chimenti, S; Citarella, L; Del Principe, I; Di Prete, M; Diluvio, L; Orlandi, A | 1 |
Sayama, K; Shiraishi, K | 1 |
1 review(s) available for prednisone and imiquimod
Article | Year |
---|---|
[Standard and experimental therapy of cutaneous T-cell lymphoma].
Topics: Adrenal Cortex Hormones; Aminoquinolines; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Lymphoma, T-Cell; Methotrexate; Photopheresis; Prednisone; PUVA Therapy; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Recombinant Proteins; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes; Vincristine | 2003 |
4 other study(ies) available for prednisone and imiquimod
Article | Year |
---|---|
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.
Topics: Adult; Aged; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Humans; Imiquimod; Immunosuppressive Agents; Interferons; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; PUVA Therapy; Remission Induction; Skin; Skin Neoplasms; Tacrolimus; Tetrahydronaphthalenes; Time Factors; Treatment Outcome; Vincristine | 2003 |
Contact pemphigus: a side-effect of imiquimod therapy.
Topics: Administration, Topical; Aminoquinolines; Azathioprine; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescent Antibody Technique, Direct; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Methylprednisolone; Middle Aged; Papillomaviridae; Papillomavirus Infections; Pemphigus; Prednisone; Risk Assessment; Treatment Outcome; Vulvar Diseases | 2008 |
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports.
Topics: Aminoquinolines; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Imiquimod; Lymphocyte Activation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Stem Cell Transplantation; Treatment Outcome; Vincristine | 2016 |
Pemphigus foliaceus induced by topical imiquimod treatment.
Topics: Adjuvants, Immunologic; Administration, Oral; Administration, Topical; Anti-Inflammatory Agents; Complement C3; Humans; Imiquimod; Immunoglobulin G; Keratosis, Actinic; Male; Middle Aged; Pemphigus; Prednisone; Treatment Outcome | 2018 |